Smart contact lens monitors eye pressure and delivers glaucoma drugs in early tests
-
By
-
Annalisa Merelli
-
April 8, 2026
-
Clinical Scorecard: Innovative Contact Lens Tracks Intraocular Pressure and Administers Glaucoma Medications in Preliminary Studies
At a Glance
| Category | Detail |
|---|
| Condition | Glaucoma |
| Key Mechanisms | Real-time monitoring of intraocular pressure and drug delivery via a theranostic contact lens. |
| Target Population | Patients with glaucoma, particularly those with ocular hypertension. |
| Care Setting | Clinical settings for glaucoma management. |
Key Highlights
- New theranostic contact lens combines monitoring and drug delivery.
- Lens adapts to changes in intraocular pressure without electronics.
- Initial tests show reliable performance in animal models.
- Potential to improve patient adherence to glaucoma medication.
- Device designed for comfort and flexibility compared to existing options.
Guideline-Based Recommendations
Diagnosis
- Regular monitoring of intraocular pressure in glaucoma patients.
Management
- Consider innovative devices for real-time monitoring and medication adherence.
Monitoring & Follow-up
- Utilize devices that provide continuous ocular pressure data.
Risks
- Potential delay in medication effect due to slow-acting drugs.
Patient & Prescribing Data
Individuals diagnosed with glaucoma, particularly those struggling with medication adherence.
Smart lens technology may enhance medication delivery and monitoring.
Clinical Best Practices
- Encourage regular follow-ups for glaucoma management.
- Assess patient comfort and lens fit during initial adaptation period.
- Monitor intraocular pressure trends for personalized treatment adjustments.
References
